Pharmaceutical Filtration Market
Pharmaceutical Filtration Market Size, Share & Trends Analysis Report by Filters (Membrane Filters, Depth Filters, Other), by Systems (Single Use, Reusable), by Other (Filtration Assemblies, Filter Holders, Filtration Accessories), by Technique (Microfiltration, Ultrafiltration, Nanofiltration, Other), by Type (Sterile Filtration, Non-Sterile Filtration), by Application (Pharmaceutical Filtration Market, by Final Product Processing, Pharmaceutical Filtration Market, by Raw Material Filtration, Cell Separation, Water Purification), by End Scale (Manufacturing Scale, Pilot Scale, R&D Scale), by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)
|Pharmaceutical Filtration Market Forecast Year:||2022 - 2028|
|Pharmaceutical Filtration Market Historical Year:||2016 - 2021|
|Pharmaceutical Filtration Market 2021:||USD 10.1 Billion|
|Pharmaceutical Filtration Projected Market 2028:||USD 24.9 Billion|
|Pharmaceutical Filtration Market CAGR:||16.3%|
|Fastest Growing Region:||Asia Pacific|
|Largest Region:||North America|
Global Pharmaceutical Filtration Market:
Pharmaceutical Filtration Market – By Filters, Systems, Technique, Type, Application, End Scale, and Region.
The Global Pharmaceutical Filtration Market is valued at USD 10.1 Billion in the year 2021 and is anticipated to reach a value of USD 24.9 Billion by the year 2028. The Global Market is forecasted to grow to exhibit a Compound Annual Growth Rate (CAGR) of 16.3% over the forecast period.
Pharmaceutical Filtration is a separation technique that involves passing processed materials through a filtration membrane to remove unwanted particles. Growing emphasis on biologics and their development for the treatment of various diseases is expected to be a major factor driving growth. One of the major features of nano-filtration membranes is their capacity to allow monovalent ions like sodium chloride to pass through while rejecting divalent and multivalent ions like sodium sulfate. Additional, advanced therapeutic medications for the treatment of chronic diseases such as cancer, diabetes, asthma, COPD, and arthritis are in high demand over the upcoming years.
Furthermore, the manufacture of innovative biologics involves ultimate sterility and zero danger of contamination, requiring the use of modern filtering products in the drug and biologics manufacturing process. The leading players are now focused on strategies such as product innovations, mergers & acquisitions, new advancements, joint ventures, collaborations, and partnerships to improve their market position in the worldwide Pharmaceutical Filtration Market.
The market's growth is projected to be limited by stringent regulatory reforms and the high cost of the filtration process. Besides, the high cost of pharmaceutical filters, as well as membrane fouling concerns, make them difficult to use in bioPharmaceutical Filtration operations. Another significant factor driving growth is increased investment in biologics research and development over the upcoming years. Also, the rapid adoption of novel treatment therapies like therapeutic proteins, monoclonal antibodies, and vaccines has resulted in a surge in the number of biotechnology and biopharmaceutical firms using filtration systems including membranes, cartridges, capsules, and other goods over the upcoming years.
Market Size Provided for Years
Region & Counties Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
The Pharmaceutical Filtration Market is segmented based on system, technique, type, other products, application, and use of operations. Based on techniques, the market is segmented as Microfiltration, Ultrafiltration, Nanofiltration, and Other Techniques. Based on applications, the market is segmented as Final Product Processing, Raw Material Filtration, Cell Separation, Water Purification, and Air Purification. Based on the end-use of operation, the market is segmented as Manufacturing Scale, Pilot Scale, and Research and Development (R&D) Scale. Based on systems, the market is segmented as single-use and reusable. Based on type, the market is segmented into sterile type and non-sterile type. Based on other filtration products, the market is segmented as Filtration Assemblies, Filter Holders, and Filtration Accessories.
Below tree is interactive. You can click the nodes to get more information.
Based on Filters:
Membrane Filters holds the largest share in the market during the forecast period. MCE (mixed cellulose ester) membrane filters coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and other membrane filters are among the several types of membrane filters available on the market. Increased adaptability and efficiency, lower operation costs, high performance, ease of use, and increased demand for good manufacturing practices (GMP) and single-use technologies in the pharmaceutical business are all driving market growth over the upcoming years.
Based on Applications:
The final processing product segment is anticipated to grow at the highest rate during the forecast period. To its extensive use in the processing of active pharmaceutical ingredients, protein purification, vaccine processing, antibody processing, and virus clearance. The adoption of innovative filters for final product processing is expected to increase as technology advances, such as cross-flow filtration, nano-fiber, and ultrafiltration technologies. Furthermore, the increasing use of biologics and other therapeutic proteins in the pharmaceutical and biopharmaceutical industries has boosted market growth by increasing the use of protein purification techniques.
North America is Projected to Grow at the Highest CAGR During the Forecast Period
North America is accounted to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. The presence of key biopharmaceutical manufacturing facilities in the region, the rising number of drug development projects, the presence of a well-established healthcare market, significant Research and Development (R&D) spending, and the presence of a well-established intellectual property system for innovative biologics account for the largest share of this segment. These businesses are forming partnerships and collaborations to achieve a larger market share. In addition, the surge in demand for Pharmaceutical Filtration products in Asia-Pacific gives attractive prospects for key players in the Pharmaceutical Filtration Market. Other drivers include prominent manufacturers' increased focus on extending their regional presence in emerging Asia-Pacific countries to capitalize on strong growth potential in the market during the forecast period.
The key players in the Pharmaceutical Filtration Market include- Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), Membrane Solutions (US).
Segmentation of Pharmaceutical Filtration Market:
Frequently Asked Questions
the global demand for Pharmaceutical Filtration
in terms of revenue?
The global Pharmaceutical Filtration valued at USD 10.1 Billion in 2020 and is expected to reach USD 24.9 Billion in 2028 growing at a CAGR of 16.3%
are the prominent players
in the market?
The prominent players in the market are Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), 3M Company (US), Eaton Corporation plc (US), Donaldson Company Inc. (US), Repligen Corporation (US), Porvair plc (UK), Alfa Laval Corporate AB (Sweden), Corning Incorporated (US), Meissner Filtration Products Inc. (US), Amazon Filters Ltd. (UK), Graver Technologies LLC (US), MMS AG (Switzerland), MANN+HUMMEL International GmbH & Co. KG (Germany), ErtelAlsop (US), Kasag Swiss AG (Switzerland), Freudenberg Filtration Technologies SE & Co. KG (Germany), Cole-Parmer Instrument Company LLC. (US), Cantel Medical Corp. (US), Filtrox AG (Switzerland), Saint-Gobain Performance Plastics (France), Membrane Solutions (US).
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 16.3% between 2021 and 2028.
the driving factors
fueling the growth of the market.
The driving factors of the Pharmaceutical Filtration include
- Growth of biopharmaceutical industry to drive filtration products demand
region accounted for the
largest share in the market?
North America was the leading regional segment of the Pharmaceutical Filtration in 2020.